The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SBGL, RMTI and GDS
NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Sibanye Gold Limited (NYSE: SBGL) Class Period: April 7, 2017 to June 26, 2018 Lead Plaintiff Deadline: August 27, 2018
The complaint alleges that during the class period Sibanye Gold Limited made materially false and/or misleading statements and/or failed to disclose that: (1) Sibanye’s safety protocols were inadequate to prevent a high rate of worker death; (2) Sibanye’s mining supervisors routinely forced Company employees to work in unsafe and unlawful conditions; the foregoing issues would foreseeably subject Sibanye to heightened regulatory oversight; and (3) as a result, Sibanye’s public statements were materially false and misleading at all relevant times.
Get additional information about the SBGL lawsuit: http://www.kleinstocklaw.com/pslra-c/sibanye-gold-limited?wire=3
Rockwell Medical, Inc. (NASDAQ: RMTI) Class Period: March 16, 2018 to June 26, 2018 Lead Plaintiff Deadline: September 25, 2018
The complaint alleges that throughout the class period Rockwell Medical, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Rockwell was aware that The Centers for Medicare and Medicaid Services will not pursue Rockwell’s proposal for separate reimbursement for the drug Triferic; (2) the estimated reserves in the first quarter 2018 10-Q are misstated; (3) there was a material weakness in Rockwell’s internal controls over financial reporting; (4) consequently, Rockwell’s internal controls over financial reporting were ineffective during the Class Period; (5) Defendant Chioini withheld material information regarding Triferic from Rockwell’s auditor, corporate counsel and five independent directors of the Board; and (6) as a result, Defendants’ statements about the Company’s business, operations and prospects were materially false and misleading and/or lacked reasonable bases at all relevant times.
Get additional information about the RMTI lawsuit: http://www.kleinstocklaw.com/pslra-c/rockwell-medical-inc?wire=3
GDS Holdings Limited (NASDAQ: GDS) Class Period: November 2, 2016 to July 31, 2018 Lead Plaintiff Deadline: October 1, 2018
The lawsuit alleges that GDS Holdings Limited made materially false and/or misleading statements and/or failed to disclose that: (1) the Company has overstated its utilization and occupancy rates; (2) the Company has made acquisitions with related parties at inflated prices; (3) it has used suspect capital and debt raisings despite large off-shore cash reserves; (4) it has adopted unorthodox accounts receivable and payable practices; and (5) that, as a result of the foregoing, Defendant’s statements about GDS’ business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.
Get additional information about the GDS lawsuit: http://www.kleinstocklaw.com/pslra-c/gds-holdings-limited?wire=3
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:Joseph Klein, Esq.Empire State Building350 Fifth Avenue59th FloorNew York, NY 10118 firstname.lastname@example.org Telephone: (212) 616-4899Fax: (347) 558-9665www.kleinstocklaw.com